Neumora Therapeutics (NMRA) PT Lowered to $7 at BofA Securities
Tweet Send to a Friend
BofA Securities analyst Geoff Meacham lowered the price target on Neumora Therapeutics (NASDAQ: NMRA) to $7.00 (from $22.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
